Lemon Verbena for Sleep: Two Positive RCTs, Product Specificity, and Limits

Bottom line: Lemon verbena has a more interesting human sleep literature than its low profile suggests. Two randomized trials reported favorable sleep outcomes, including one with actigraphy. The evidence is still preparation-specific and not independently replicated enough for a strong insomnia-treatment claim.

The 2018 insomnia trial

A double-blind placebo-controlled trial randomized 100 adults with insomnia to a lemon-verbena syrup or placebo for four weeks.[1]

The active group improved more on the Pittsburgh Sleep Quality Index and Insomnia Severity Index, including sleep latency, efficiency, daytime dysfunction, and subjective sleep quality.

That is direct clinical evidence rather than a mechanism-only story.

The 2024 study adds objective measurement

A later randomized double-blind study enrolled 71 healthy adults with sleep disturbances and tested a standardized Aloysia citrodora extract for 90 days.[2]

Subjective sleep quality improved compared with placebo.

More importantly, several actigraphy-derived measures also favored the intervention, including sleep latency, efficiency, wakefulness after sleep onset, and awakenings.[2]

Objective wearable-style measures are useful because they reduce reliance on questionnaire reporting alone.

The products were not identical

The 2018 study used a syrup characterized by essential-oil and flavonoid content.

The 2024 study used a standardized commercial extract.

Those are not automatically equivalent preparations.

A reader should not assume that tea, essential oil, powdered leaf, tincture, and standardized extract all deliver the same constituents at the same exposure.

Commercial context matters

The 2024 paper disclosed that several authors were employees of the company connected to the studied extract.[2]

Industry involvement does not make a result invalid.

It increases the value of independent replication, especially when a literature is still small and product-specific.

Is this enough to call lemon verbena an insomnia treatment?

Not yet.

Two positive trials are meaningful, but the total participant count is still modest, preparations differ, and independent replication is limited.

For persistent chronic insomnia, evidence-based behavioral treatment remains a much more established benchmark.

What would turn an emerging signal into stronger evidence?

Independent replication is the biggest missing piece. A larger trial using a clearly described lemon-verbena preparation could test whether the positive subjective and actigraphy findings reproduce outside the commercial development context and across a broader range of participants.

The intervention also needs to stay traceable. Tea, syrup, powdered leaf, essential oil, and a standardized extract can differ substantially in composition, so a result from one preparation should not upgrade every product carrying the same plant name. Dose, extraction method, marker compounds, and duration belong with the claim.

Future studies would be easier to compare if they prespecified a small set of clinically meaningful sleep outcomes and reported null results just as prominently as positive ones. That would help distinguish a reproducible sleep effect from a pattern created by many possible endpoints in a still-small literature.

Verdict

Lemon verbena has emerging human evidence for sleep quality, stronger than many obscure sleep herbs but not yet robust enough for a broad treatment claim.

It is a good candidate for continued tracking because the 2024 actigraphy results move the field beyond purely subjective outcomes.